EcoDrugPlus

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSCDRG00005007344
Gene Symbol: TIE1
3 Cross references
205 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSCDRG00005010083
Gene Symbol: UTS2R
1 Cross references
92 Possible Orthologues:

Utrophin

Ensembl ID : ENSCDRG00005008477
Gene Symbol: UTRN
1 Cross references
268 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSCDRG00005015143
Gene Symbol: VEGFA
1 Cross references
254 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSCDRG00005011877
Gene Symbol: VDR
3 Cross references
466 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1

Ensembl ID : ENSCDRG00005013244
Gene Symbol: VKORC1
1 Cross references
190 Possible Orthologues:

Xanthine Dehydrogenase

Ensembl ID : ENSCDRG00005014145
Gene Symbol: XDH
3 Cross references
210 Possible Orthologues:

Ensembl ID : ENSCDRG00005017303
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCDRG00005018687
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSCDRG00005018295
Gene Symbol: -
Cross references: -
316 Possible Orthologues:

Ensembl ID : ENSCDRG00005018244
Gene Symbol: -
Cross references: -
316 Possible Orthologues:

Ensembl ID : ENSCDRG00005003051
Gene Symbol: -
Cross references: -
276 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).